Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-09-19

FDA Approved: LORYNA — Supplemental Application (Xiromed, LLC.)

View source ↗

Summary

FDA approved a supplemental application for LORYNA (DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS) from Xiromed, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LORYNA (DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS)

Snippet

SUPPL AP for LORYNA (DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS)